PATRONO, Carlo
 Distribuzione geografica
Continente #
NA - Nord America 2.646
AS - Asia 1.850
EU - Europa 1.804
SA - Sud America 136
AF - Africa 15
Continente sconosciuto - Info sul continente non disponibili 5
OC - Oceania 2
Totale 6.458
Nazione #
US - Stati Uniti d'America 2.606
SG - Singapore 712
CN - Cina 612
UA - Ucraina 368
IE - Irlanda 312
TR - Turchia 298
SE - Svezia 259
GB - Regno Unito 222
DE - Germania 174
FR - Francia 163
BR - Brasile 115
IT - Italia 109
IN - India 108
FI - Finlandia 91
RU - Federazione Russa 60
VN - Vietnam 40
CA - Canada 19
HK - Hong Kong 18
MX - Messico 14
PL - Polonia 14
AR - Argentina 12
ZA - Sudafrica 8
BE - Belgio 7
IQ - Iraq 7
JP - Giappone 7
NL - Olanda 7
BD - Bangladesh 6
IL - Israele 6
EU - Europa 5
ID - Indonesia 5
SA - Arabia Saudita 5
AT - Austria 4
CZ - Repubblica Ceca 4
EG - Egitto 4
ES - Italia 4
IR - Iran 4
KR - Corea 4
TW - Taiwan 4
UY - Uruguay 4
HN - Honduras 3
AU - Australia 2
BB - Barbados 2
CL - Cile 2
JO - Giordania 2
KG - Kirghizistan 2
QA - Qatar 2
VE - Venezuela 2
AM - Armenia 1
BN - Brunei Darussalam 1
CG - Congo 1
DZ - Algeria 1
EC - Ecuador 1
EE - Estonia 1
GD - Grenada 1
GE - Georgia 1
KH - Cambogia 1
LB - Libano 1
LT - Lituania 1
MA - Marocco 1
MT - Malta 1
NI - Nicaragua 1
NO - Norvegia 1
NP - Nepal 1
PH - Filippine 1
PK - Pakistan 1
RO - Romania 1
RS - Serbia 1
Totale 6.458
Città #
Singapore 544
Jacksonville 411
Chandler 365
Dublin 310
Beijing 184
Southend 172
Izmir 147
Princeton 143
Ashburn 133
Dallas 126
Wilmington 105
Nanjing 102
Santa Clara 86
Los Angeles 83
Dearborn 75
Cambridge 67
Buffalo 45
Munich 44
New York 44
The Dalles 42
Ann Arbor 41
Tongling 39
Nanchang 36
Woodbridge 35
Altamura 29
Shenyang 23
Kunming 21
Helsinki 19
Ho Chi Minh City 19
Boardman 18
Hong Kong 18
Jiaxing 18
Grevenbroich 17
Hebei 17
Changsha 15
Houston 15
São Paulo 15
Washington 15
Augusta 14
Hefei 13
Norwalk 13
Chieti 12
Moscow 12
Redondo Beach 12
Tianjin 12
Council Bluffs 11
Warsaw 11
San Mateo 10
Brooklyn 9
Falls Church 9
Hangzhou 9
Chennai 8
Chicago 8
Lanzhou 8
Orange 8
Seattle 8
Boston 7
Brussels 7
Hanoi 7
Jinan 7
Johannesburg 7
Leawood 7
Montreal 7
Tokyo 7
Orem 6
Phoenix 6
Shanghai 6
Stockholm 6
Denver 5
Frankfurt am Main 5
Poplar 5
Querétaro 5
San Francisco 5
Toronto 5
Turku 5
Zhengzhou 5
Atlanta 4
Belo Horizonte 4
Brno 4
Hackney 4
Milan 4
Padua 4
Queens 4
San Jose 4
Seoul 4
Taiyuan 4
Tavagnacco 4
Amsterdam 3
Campinas 3
Charlotte 3
Erbil 3
Guangzhou 3
Kocaeli 3
Manchester 3
Montevideo 3
Mountain View 3
New Delhi 3
Pescara 3
Pune 3
Roubaix 3
Totale 4.028
Nome #
Low-dose aspirin acetylates cyclooxygenase-1 in human colorectal mucosa: implications for the chemoprevention of colorectal cancer. 158
Enhanced lipid peroxidation and platelet activation in the early phase of type 1 diabetes mellitus: role of interleukin-6 and disease duration. 150
Variability in the Recovery Rate of Platelet Cyclooxygenase Activity During Chronic Therapy With Low-Dose Aspirin in Type 2 Diabetes. 138
Platelet Cyclooxygenase Inhibition by Low-Dose Aspirin Is Not Reflected Consistently by Platelet Function Assays. Implications for Aspirin "Resistance" 133
Platelet-specific deletion of cyclooxygenase-1 ameliorates dextran sulfate sodium-induced colitis in mice. 127
Thromboxane-dependent CD40 ligand release in type 2 diabetes mellitus 124
Thromboxane biosynthesis and pulmonary function in cystic fibrosis 121
Platelet cyclooxygenase inhibition by low-dose aspirin is not reflected consistently by platelet function assays. implications for aspirin 'resistance'. 120
Determinants of the Variability in the Recovery Rate of Platelet Cyclooxygenase Activity during Chronic Therapy with Low-Dose Aspirin in Type 2 Diabetes 116
Vitamin E inhibits enhanced F2 isoprostane biosynthesis in type IIA hypercholesterolemia 115
Insulin resistance as a determinant of platelet activation in obese women. 112
Cyclooxygenase-2 expression and inhibition in atherothrombosis. 107
Aspirin after acute myocardial infarction: a systematic approach to compare the hemostatic effects of three different doses. 106
Platelet cyclooxygenase inhibition by low-dose aspirin is not reflected consistently by platelet function assays: implications for aspirin "resistance". 106
In vivo formation of 8-iso-prostaglandin f2alpha and platelet activation in diabetes mellitus: effects of improved metabolic control and vitamin E supplementation. 105
Immunological characterization uf urinary 8-epi-prostaglandin f2alfa excretion in man 104
Platelet Activation and Lipid Peroxidation in Patients With Acute Ischemic Stroke. 104
Thromboxane and prostacyclin biosynthesis in heart failure of ischemic origin: effects of disease severity and aspirin treatment. 103
Increased thromboxane production by monocyte prostaglandin endoperoxide synthase-2 in patients with acute myocardial infarction (pubbl. su Suppl. Circulation) 102
Aspirin, platelet inhibition and cancer prevention. 102
Determinants of platelet activation in Alzheimer's disease 100
In vivo formation of 8-epi-prostaglandin F2alpha in diabetes mellitus. Effects of tight metabolic control and vitamin E supplementation. (pubbl su Suppl Thromb Haemostas) 99
Cyclooxygenase-2 polymorphism: putting a brake on the inflammatory response to vascular injury? 99
Differential suppression of thromboxane biosynthesis by indobufen and aspirin in patients with unstable angina. 98
Postprandial hyperglycemia is an important determinant of platelet activation. evidence from biochemical measurements and pharmacological intervention with acarbose 98
In vivo formation of 8-epi-prostaglandin F2alpha in diabetes mellitus. Effects of tight metabolic control and vitamin E supplementation 98
Determinants of platelet activation in human essential hypertension. 98
Effects of nabumetone on prostanoid biosynthesis in humans. 97
In vivo formation of 8-Epi-prostaglandin F2 alpha is increased in hypercholesterolemia. 97
Differential Expression and Regulation of Cyclooxygenase Isozymes in Thymic Stromal Cells. 97
Role of Platelet Activation in Dementia 96
Mechanisms, consequences, and prevention of coronary graft failure 96
Platelets as a source of CD40 ligand in type 2 diabetes mellitus 96
Increased thromboxane biosynthesis in essential thrombocythemia 95
Postprandial hyperglycemia is an important determinant of platelet activation in early type 2 diabetes mellitus. Evidence from biochemical measurements and pharmacological intervention with acarbose. 95
Insulin resistance as a determinant of platelet activation in obese women 92
Drugs, prostaglandins, and renal function. 90
Thromboxane and prostacyclin biosynthesis in heart failure of ischemic origin: effects of disease severity and aspirin treatment. 90
Determinants of Thromboxane-Dependent Platelet Activation in Heart Failure. 90
Nutraceuticals in diabetes and metabolic syndrome. 89
Antiplatelet agents in the prevention of diabetic vascular complications 89
In vivo formation of 8-epi-prostaglandin F2alpha in increased in hypercholesterolemia. An aspirin-insensitive amplification mechanism of platelet activation (pubbl su Suppl Thromb Haemostas) 88
Effects of Acarbose on in Vivo Markers of Oxidative Stress and Platelet Activation in Early Type 2 Diabetes 87
Determinants of Platelet Activation in Heart Failure. 87
Platelet activation in obese women: role of inflammation and oxidant stress. 85
In vivo formation of 8-iso-prostaglandin F2a and aspirin-insensitive thromboxane biosynthesis in unstable angina 83
Soluble CD40L as an indicator of platelet Activation in Heart Failure 83
Effects of Acarbose on in Vivo Markers of Oxidative Stress and Platelet Activation in Early Type 2 Diabetes. 83
Oxidative Stress and Platelet Activation in Subjects with Moderate Hyperhomocysteinemia Due to MTHFR 677 C->T Polymorphism. 82
Cyclooxygenase-2 expression and inhibition in human monocytes 82
Abnormally high thromboxane biosynthesis in homozygous homocystinuria. Evidence for platelet involvement and probucol-sensitive mechanism 81
Thromboxane and prostacyclin biosynthesis in heart failure of ischemic origin: effects of disease severity and aspirin treatment. 79
Determinants of Platelet Activation in Heart Failure. 78
Effects of vitamin E supplementation on F2-isoprostane and thromboxane biosynthesis in healthy cigarette smokers. 77
In vivo formation of 8-EPI-prostaglandin F2 alpha in diabetes mellitus. Effects of tight metabolic control and vitamin E supplementation 77
Short term Vitamin E treatment normalizes LDL oxidative susceptibility in diabetic subjects. 76
Effects of the novel anti-inflammatory compounds, N-[2-(cyclohexyloxy)-4-nitrophenyl] methanesulphonamide (NS-398) and 5-methanesulphonamido-6-(2,4-difluorothiophenyl)-1-indanone (L-745,337), on the cyclo-oxygenase activity of human blood prosta-glandin endoperoxide synthases 75
In vivo formation of 8-isoprostaglandin F-2 alpha and platelet activation in diabetes mellitus. Effects of improved metabolic control and vitamin E supplementation 75
Abnormally high thromboxane biosynthesis in homozygous homocystinuria. Evidence for platelet involvement and probucol-sensitive mechanism 75
Insulin resistance as a determinant of platelet activation in obese women 74
Effects of successful weight loss or pioglitazone on thromboxane-dependent platelet activation in obese women 72
Oxidative Stress and Platelet Activation in Subjects with Moderate Hyperhomocysteinemia Due to MTHFR 677 C->T Polymorphism 72
Thromboxane biosynthesis in cardiovascular diseases 69
Homocysteine, methylenetetrahydrofolate reductase, folate status and atherothrombosis: A mechanistic and clinical perspective 69
Oxidative Stress and Platelet Activation in Subjects with Moderate Hyperhomocysteinemia Due to MTHFR 677 C->T Polymorphism 68
Thromboxane biosynthesis and metabolism in relation to cardiovascular risk factors 65
Oxidative Stress and Platelet Activation in Subjects with Moderate Hyperhomocysteinemia Due to MTHFR 677 C->T Polymorphism. 62
Fractional conversion of thromboxane B2 to urinary 11-dehydrothromboxane B2 in man 61
Long‐term pharmacodynamic and clinical effects of twice‐ versus once‐daily low‐dose aspirin in essential thrombocythemia: The ARES trial 59
Increased thromboxane biosynthesis in type IIa hypercholesterolemia 58
In vivo platelet activation in diabetes mellitus 48
Off-pump coronary artery bypass grafting: 30 years of debate 33
Totale 6.615
Categoria #
all - tutte 27.156
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 27.156


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021286 0 0 0 0 0 100 3 4 79 70 10 20
2021/2022275 1 4 6 47 26 5 7 18 25 9 41 86
2022/2023989 81 129 80 98 89 211 57 62 125 13 19 25
2023/2024417 32 10 31 13 30 113 126 18 2 3 5 34
2024/20251.184 95 283 202 16 9 41 12 29 79 41 128 249
2025/20261.151 236 114 222 261 288 30 0 0 0 0 0 0
Totale 6.615